clinical trials for glp-1 GLP1 agonists: current and future landscape of patients with metabolic dysfunction GLP-1 Clinical Trials and eCOA

By lipidomic measurement, the content of lipid peroxides in cells was significantly reduced after transfection of the iNOS plasmid

Novel insights in the relationship of gut microbiota and coronary artery diseases

doi: 10.12998/wjcc.v4.i8.248

Can Semax or Selank Make Anxiety Worse

PBPK integrates information such as system properties, drug properties, formulation properties, and anatomical structures of tissues or organs through mathematical models, which can provide a comprehensive description of the in vivo PK behavior of drugs ( in vivo , as well as the effects of disease and physiological factors on PK behavior